| pubmed-article:7041728 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7041728 | lifeskim:mentions | umls-concept:C1705480 | lld:lifeskim |
| pubmed-article:7041728 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:7041728 | lifeskim:mentions | umls-concept:C0041909 | lld:lifeskim |
| pubmed-article:7041728 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:7041728 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:7041728 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:7041728 | pubmed:dateCreated | 1982-6-24 | lld:pubmed |
| pubmed-article:7041728 | pubmed:abstractText | Sixty patients with active upper gastrointestinal bleeding were randomized to received either continuous intravenous infusions of vasopressin (29 patients) or placebo (31 patients) at a rate of 40 U/h. Six hours after beginning the study, 13 patients in the vasopressin group and 11 in the placebo group] had ceased bleeding (p = 0.46). By 24 hours. 17 patients in the vasopressin group and 14 in the placebo group had stopped bleeding (p = 0.30). Restriction of the analysis to patients bleeding from varices showed no advantage with vasopressin treatment after 6 or 24 hours. No consistent trend favoring use of vasopressin to stop hemorrhage was noted during the 30-month study period. There was little difference between the two groups in the number of patients needing surgery (13 on vasopressin, 18 on placebo; p = 0.30) or the number of deaths (eight on vasopressin, 11 on placebo; p = 0.51); the transfusion requirement was the same. In our patients, a continuous intravenous infusion of vasopressin neither controlled bleeding nor altered outcome. | lld:pubmed |
| pubmed-article:7041728 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7041728 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7041728 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7041728 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7041728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7041728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7041728 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7041728 | pubmed:month | May | lld:pubmed |
| pubmed-article:7041728 | pubmed:issn | 0003-4819 | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:WalkerJ EJE | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:AndrewL PLP | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:KnauerC MCM | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:GregoryP BPB | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:MahalA SAS | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:FogelM RMR | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:SiegmundDD | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:SteinD EDE | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:RinkiM MMM | lld:pubmed |
| pubmed-article:7041728 | pubmed:author | pubmed-author:KemenyM JMJ | lld:pubmed |
| pubmed-article:7041728 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7041728 | pubmed:volume | 96 | lld:pubmed |
| pubmed-article:7041728 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7041728 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7041728 | pubmed:pagination | 565-9 | lld:pubmed |
| pubmed-article:7041728 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:meshHeading | pubmed-meshheading:7041728-... | lld:pubmed |
| pubmed-article:7041728 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:7041728 | pubmed:articleTitle | Continuous intravenous vasopressin in active upper gastrointestinal bleeding. | lld:pubmed |
| pubmed-article:7041728 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7041728 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7041728 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7041728 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7041728 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7041728 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7041728 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7041728 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7041728 | lld:pubmed |
